8th International CLL Workshop Salzburg Program

8th International CLL Workshop Salzburg Program

Update on Biology and Therapy of
Chronic Lymphocytic Leukemia
8 th International
CLL Workshop
The workshop which will be held on May 4th and May
5th 2012 at the Hotel Jagdhof directly at Lake Fuschl.
The conference will provide an update of the most re-
Scientific Organizing Committee:
Univ. Prof. Dr. Richard Greil, Salzburg
Dr. Tanja N. Hartmann, Salzburg
cent insights into basic and clinical aspects of this disease. The very short distance to Salzburg City and the
Salzburg International Airport will guarantee easy access to the conference location. We are confident that
this workshop with a very ambitious scientific program
Laboratory for Immunological and Molecular
Cancer Research
May 4th & 5th 2012
Fuschl am See, Salzburg
University Clinics of Internal Medicine III with
Hematology, Oncology, Hemostaseology, Infectiology and
Rheumatology, Salzburg, Austria
will be most memorable to you.
Contact persons:
Dr. Angelina Miloloza – Mundipharma GmbH, Vienna
Dr. Veronika Huter – Roche GmbH, Vienna
Dr. Uwe Händel – Celgene GmbH, Vienna
Workshop Venue:
Hotel Jagdhof
Schlosstrasse 1
5322 Hof bei Salzburg, Austria
www.hoteljagdhof-fuschlsee.at
Kindly supported by:
Update on Biology and
Therapy of Chronic
Lymphocytic Leukemia
Scientific Program
Scientific Program
Friday, May 4th
9.50 – 10.15
17.30 – 18.30
Christoph Plass (Heidelberg, Germany)
Keynote Lecture
Cellular and molecular cues and targets in CLL
Rajendra N. Damle
(The Feinstein Institute for Medical Research
New York, USA)
Global epigenetic alternations in CLL
Chair: Ulrich Jäger (Vienna, Austria)
10.15 – 10.40
19.00
10.40 – 11.05
Dinner
Novel components of death receptor signaling
Saturday, May 5th
11.05 – 11.30
Session I
Genetics and Epigenetics
8.45 – 9.25
Large-scale genome analysis of CLL reveals novel
cancer genes including SF3B1
Catherine J. Wu (Dana-Farber Cancer Institute, Boston, USA)
9.25 – 9.50
Genetics of ”refractory“ CLL
Thorsten Zenz (Heidelberg, Germany)
Session III
Clinical Aspects
Lukáš Smolej (Hradec Králové, Czech Republic)
Welcome Reception
8.45
13.45
10.40
18.30
Richard Greil (Salzburg, Austria)
Lunch Break
13.45 – 14.20
Session II
Signaling Pathways
Welcome and Introduction
12.45 – 13.45
Coffee Break
Chair: Richard Greil (Salzburg, Austria)
8.30 – 8.45
Scientific Program
Lukas Frenzel (Cologne, Germany)
PD1 in CLL
Roland Geisberger (Salzburg, Austria)
11.30 – 11.55
Signaling through Rho and Rac in CLL
Sebastian Hofbauer (Salzburg, Austria)
11.55 – 12.20
Lipid metabolism in CLL
Clemens Wendtner (Munich/Cologne, Germany)
12.20 – 12.45
Functional consequences of ZAP70 for
disease progression of CLL
Ingo Ringshausen (Munich, Germany)
Chair: Christian Peschel (Munich, Germany)
Overview and Introduction
Controversial issues in the management of CLL
14.20 – 15.45
Case Studies
Alexander Egle (Salzburg, Austria)
Thomas Melchardt (Salzburg, Austria)
Lukas Weiss (Salzburg, Austria)
Michael Steurer (Innsbruck, Austria)
Discussants
Clemens Wendtner (Munich/Cologne, Germany)
Lukáš Smolej (Hradec Králové, Czech Republic)
Ulrich Jäger (Vienna, Austria)
Christian Peschel (Munich, Germany)
Chair and Moderation of Discussion
Richard Greil (Salzburg, Austria)
15.45 – 16.00
Summarizing Comments
Richard Greil (Salzburg, Austria)